Mancini Anthony

See Remarks

Mancini Anthony has filed 8 SEC Form 4 filings (27 transaction rows) across 1 company, with disclosures dating back to 2026. 8 of those filings fall inside the rolling window. Most recent filing: Sep 28, 2026.

On the most recent filing, Mancini Anthony is listed as See Remarks at Revolution Medicines, Inc. Inside the rolling window, Mancini Anthony reported no open-market purchases and 9 open-market sales totaling $9.8M in RVMD. The largest disclosed transaction in the window is a sale of 37,450 RVMD shares on Mar 25, 2026, worth $3.6M.

Companies traded

Other insiders at RVMD

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$9.8M

reported sales (SEC code S)

Companies

1

in the rolling window

Source
RVMDSale$117KSep 28SEC ↗
RVMDSale$626KSep 28SEC ↗
RVMDSale$347KSep 22SEC ↗
RVMDSale$353KSep 18SEC ↗
RVMDSale$3.2MSep 14SEC ↗
RVMDSale$720KJun 18SEC ↗
RVMDSale$481KMay 28SEC ↗
RVMDSale$413KApr 29SEC ↗
RVMDSale$3.6MMar 26SEC ↗
Showing 1–9 of 9
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Mancini Anthony made?

Mancini Anthony has filed 8 SEC Form 4 filings (27 transaction rows) across 1 company since 2026.

Which companies does Mancini Anthony trade?

Mancini Anthony has filed SEC Form 4 disclosures for 1 company, including RVMD.

When was Mancini Anthony's most recent SEC Form 4 filing?

Mancini Anthony's most recent SEC Form 4 filing on Tracefour is dated Sep 28, 2026.

What is Mancini Anthony's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, Mancini Anthony is listed as See Remarks.

What is Mancini Anthony's total buy and sell value in the current window?

Inside the rolling retention window, Mancini Anthony bought $0 and sold $9.8M based on SEC Form 4 filings.

What was Mancini Anthony's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 37,450 RVMD shares on 2026-03-25, worth $3.6M, per SEC Form 4 filings.